Internal Medicine, Rheumatology · Huntsville, AL
NPI
1174900864
Since 2015
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4606 Bellewood Dr
Huntsville, AL, 35802
Phone (256) 551-6510
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
83,276 services
Medicare patients, 2024
612
Average age 74
Drug cost, 2024
$4.7M
4,963 prescriptions
Company payments, 2025
$2,541
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret J Meehan was code J3262 (injection, tocilizumab, 1 mg), 22,720 times for 18 patients. In total Margaret J Meehan billed 83,276 services in 67 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 22,720 | 18 | $4.69 | $106K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 19,125 | 44 | $9.02 | $173K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 13,860 | 15 | $8.61 | $119K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,050 | 19 | $32.68 | $198K |
| J0897 Injection, denosumab, 1 mg | Office | 2,162 | 35 | $20.97 | $45K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,420 | 15 | $24.94 | $35K |
| 99214 Office E&M - Established | Office | 1,042 | 524 | $84.32 | $88K |
| 85025 Blood Count | Office | 887 | 418 | $7.57 | $6,712 |
| 80053 Clinical Chemistry | Office | 702 | 342 | $10.29 | $7,227 |
| 36415 Venipuncture Blood Collection | Office | 644 | 350 | $7.92 | $5,100 |
| 86235 Immunoassay | Office | 528 | 66 | $17.33 | $9,151 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 319 | 139 | $0.50 | $160 |
| 82306 Clinical Chemistry | Office | 311 | 243 | $28.85 | $8,971 |
| 99213 Office E&M - Established | Office | 263 | 161 | $61.04 | $16K |
| 96365 Intravenous Infusion, Hydration | Office | 221 | 101 | $43.46 | $9,604 |
By year: 2022 $694K for 40,896 services; 2023 $856K for 51,337 services; 2024 $1.0M for 83,276 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 887 | 418 | $7.57 | $6,712 |
| 80053 Clinical Chemistry | 702 | 342 | $10.29 | $7,227 |
| 36415 Venipuncture Blood Collection | 644 | 350 | $7.92 | $5,100 |
| 86235 Immunoassay | 528 | 66 | $17.33 | $9,151 |
| 82306 Clinical Chemistry | 311 | 243 | $28.85 | $8,971 |
| 80048 Clinical Chemistry | 182 | 131 | $8.26 | $1,503 |
| 84550 Clinical Chemistry | 127 | 84 | $4.40 | $559 |
| 82550 Clinical Chemistry | 102 | 66 | $6.38 | $651 |
| 86431 Immunoassay | 95 | 94 | $5.51 | $523 |
| 84443 Clinical Chemistry | 73 | 73 | $16.28 | $1,188 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret J Meehan prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 820 prescriptions and refills. In total Margaret J Meehan wrote 4,963 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 820 | 1,321 | 190 | $24K |
| Hydroxychloroquine Sulfate Generic | 651 | 1,279 | 176 | $30K |
| Prednisone Generic | 559 | 867 | 135 | $4,325 |
| Allopurinol Generic | 239 | 553 | 54 | $3,033 |
| Tramadol Hcl Generic | 225 | 225 | 48 | $1,021 |
| Alendronate Sodium Generic | 211 | 441 | 69 | $2,200 |
| Meloxicam Generic | 173 | 318 | 52 | $960 |
| Gabapentin Generic | 147 | 147 | 29 | $1,085 |
| Leflunomide Generic | 142 | 250 | 38 | $9,082 |
| Methylprednisolone Generic | 131 | 131 | 82 | $1,018 |
| Humira(Cf) Pen Adalimumab | 125 | 130 | 20 | $951K |
| Colchicine Generic | 98 | 153 | 23 | $3,475 |
| Folic Acid Generic | 70 | 174 | 25 | $352 |
| Rinvoq Upadacitinib | 68 | 68 | Under 11 | $445K |
| Celecoxib Generic | 65 | 107 | 20 | $2,006 |
Brand drugs: 828 claims; generic drugs: 4,100 claims; opioid claims: 234.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret J Meehan $2,541 ($2,541 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $575.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $575 |
| Amgen Inc. AMGN | 24 | $399 |
| Novartis Pharmaceuticals Corporation NVS | 25 | $366 |
| GlaxoSmithKline, LLC. GSK | 11 | $291 |
| UCB, Inc. UCB.BR | 13 | $218 |
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $203 |
| Janssen Biotech, Inc. JNJ | 12 | $176 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $90.53 |
| Organon LLC OGN | 3 | $55.69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.